State Street
TMDX icon

State Street’s Transmedics TMDX Stock Holding History

State Street’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$131M Buy
1,319,479
+44,346
+3% +$5.78M ﹤0.01% 1219
2025
Q4 		$155M Sell
1,275,133
-4,408
-0.3% -$553K 0.01% 1101
2025
Q3 		$144M Sell
1,279,541
-9,469
-0.7% -$1.11M 0.01% 1140
2025
Q2 		$173M Sell
1,289,010
-17,525
-1% -$1.92M 0.01% 1002
2025
Q1 		$87.9M Sell
1,306,535
-54,724
-4% -$3.76M ﹤0.01% 1340
2024
Q4 		$84.9M Buy
1,361,259
+88,128
+7% +$8.2M ﹤0.01% 1441
2024
Q3 		$200M Buy
1,273,131
+490,345
+63% +$75.6M 0.01% 917
2024
Q2 		$118M Buy
782,786
+7,907
+1% +$948K 0.01% 1166
2024
Q1 		$57.3M Sell
774,879
-12,199
-2% -$1.01M ﹤0.01% 1651
2023
Q4 		$62.1M Buy
787,078
+284
+0% +$17.1K ﹤0.01% 1589
2023
Q3 		$43.1M Buy
786,794
+5,650
+0.7% +$407K ﹤0.01% 1709
2023
Q2 		$65.6M Buy
781,144
+40,822
+6% +$3.12M ﹤0.01% 1498
2023
Q1 		$56.1M Buy
740,322
+32,930
+5% +$2.28M ﹤0.01% 1577
2022
Q4 		$43.7M Buy
707,392
+13,250
+2% +$704K ﹤0.01% 1728
2022
Q3 		$29M Buy
694,142
+36,716
+6% +$1.6M ﹤0.01% 1961
2022
Q2 		$20.7M Sell
657,426
-12,118
-2% -$323K ﹤0.01% 2212
2022
Q1 		$18M Sell
669,544
-148,896
-18% -$2.67M ﹤0.01% 2486
2021
Q4 		$15.7M Buy
818,440
+17,169
+2% +$430K ﹤0.01% 2645
2021
Q3 		$26.5M Sell
801,271
-18,642
-2% -$570K ﹤0.01% 2274
2021
Q2 		$27.2M Buy
819,913
+297,593
+57% +$8.25M ﹤0.01% 2311
2021
Q1 		$21.7M Buy
522,320
+131,752
+34% +$4.05M ﹤0.01% 2329
2020
Q4 		$7.77M Buy
390,568
+52,340
+15% +$775K ﹤0.01% 2763
2020
Q3 		$4.66M Buy
338,228
+27,133
+9% +$465K ﹤0.01% 2819
2020
Q2 		$5.58M Buy
311,095
+76,701
+33% +$1.2M ﹤0.01% 2707
2020
Q1 		$2.83M Buy
234,394
+42,610
+22% +$714K ﹤0.01% 2902
2019
Q4 		$3.65M Buy
191,784
+85,937
+81% +$1.58M ﹤0.01% 2999
2019
Q3 		$2.51M Buy
105,847
+22,806
+27% +$547K ﹤0.01% 3137
2019
Q2 		$1.54M Buy
+83,041
New +$2.27M ﹤0.01% 3332

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

State Street's TMDX Position: Q1 2026 in Review

State Street increased its Transmedics (TMDX) stake by 3.5% in Q1 2026, buying an estimated $5.78M and bringing the position to 1,319,479 shares worth $131M. The position accounts for ﹤0.01% of the portfolio, ranked #1219.

State Street first reported a position in TMDX in Q2 2019 and has held it in 28 quarters since. The position peaked at $200M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • State Street held 1,319,479 shares of Transmedics worth $131M as of Q1 2026.
  • State Street bought 44,346 Transmedics shares in Q1 2026, an estimated $5.78M.
  • Transmedics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #1219 holding.
  • State Street first reported a position in Transmedics in Q2 2019 and has held it in 28 quarters since.
  • State Street's Transmedics position peaked at $200M in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.